Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Multicenter Randomized Control Study to Investigate the Incidence of NODAT (New-Onset Diabetes After Transplantation), Safety and Efficacy of Corticosteroids Early Withdrawal in Liver Transplanted Recipients

NCT02095418 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02095418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02095418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Multicenter Randomized Control Study to Investigate the Incidence of NODAT (New-Onset Diabetes After Transplantation), Safety and Efficacy of Corticosteroids Early Withdrawal in Liver Transplanted Recipients
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2014
Completion date
February 28, 2018
Enrollment
152 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes